Filter

251 - 260 of 363 Results

  • AI Chatbots as Health Information Sources — The Monitor

    Feature

    In this issue, we take a closer look at the reliability of artificial intelligence (AI) chatbots as a source of health information. We explore public opinion on chatbot accuracy based on KFF surveys and highlight recent examples of AI-generated election misinformation in the news. In addition, we share our firsthand experience querying AI chatbots on health topics and discuss research on gaps in safeguards.

  • Most Black and Hispanic Adults Expect to Get the New COVID-19 Vaccine, Though Most White Adults Don’t

    News Release

    The latest KFF COVID-19 Vaccine Monitor survey reveals that half (51%) of all adults nationally say they “definitely” or “probably” will not get the latest COVID-19 vaccine, with many saying that they aren’t worried about catching the virus. One in five (20%) say that they’ve already gotten the new vaccine that became available in September, with an additional 28% saying they “definitely” or “probably” will get the new shot. The rest say they “definitely” or…

  • U.S. Measles Outbreaks: A New Abnormal in a Time of Vaccine Hesitancy

    Quick Insights

    Given the current trends and embrace of vaccine skepticism on the part of the administration, and potential changes to federal policy around childhood vaccines, we might continue to witness more and longer outbreaks of preventable disease — and just maybe lose our measles elimination status, which as a country we’ve had for 25 years.

  • Race-Based Vaccine Myths Spread Amid Measles Outbreaks — The Monitor

    Feature

    This volume discusses the spread of race-based vaccine myths and shifts in health communication from fact-checking to fostering open dialogue. It also explains common misconceptions about heart attack treatment and prevention, a new scientific journal that questions established science, and gaps in research standards for AI chatbots used in healthcare.

  • Flawed Report Aims to Undercut Established Research on Abortion Pill Safety, Plus How a Federal Initiative to Study Autism May Overemphasize Environmental Toxins — The Monitor

    Feature

    This volume highlights how a report criticized for flawed methodology is influencing renewed efforts to restrict access to mifepristone; a federal plan to study the causes of autism that could be contributing to stigma by over-emphasizing environmental toxins; and the resurgence of false claims about fetal tissue in vaccines.

  • KFF Health Misinformation Tracking Poll Pilot

    Poll Finding

    The poll reveals that at least four in ten U.S. adults saying they’ve heard each of 10 specific false claims about COVID-19, reproductive health, and gun violence. While relatively small shares definitely believes the false claims, many more are uncertain about them. The survey also examines the public’s social and traditional media use and trust in sources of health information.

  • Large Shares of Black Adults, Hispanic Adults, and Rural Residents are Unsure Whether to Believe Many False Health Claims  

    News Release

    Drawing on KFF’s Misinformation Pilot Poll, KFF today released three follow-up reports examining exposure to, and belief in, health misinformation among Black adults, Hispanic adults, and rural communities. As with the general public, large shares within each group are uncertain about whether each of 10 false health claims are true or not, describing them as either “probably true” or “probably false.” This uncertainty leaves people vulnerable to misinformation but also provides an opportunity to combat…

  • Poll: Trust in Public Health Agencies and Vaccines Falls Amid Republican Skepticism

    News Release

    As President Trump begins his second term, the public’s trust in health information from key health agencies has fallen over the past 18 months, continuing a decline that began during the COVID-19 pandemic, finds the new KFF Tracking Poll on Health Information and Trust.  Just over half (53%) of the public now says they trust the Food and Drug Administration (FDA) to make the right recommendations on health issues at least “a fair amount,” down…